Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aurinia Pharmaceuticals

7.66
-0.0900-1.16%
Post-market: 7.660.00000.00%16:43 EDT
Volume:943.61K
Turnover:7.28M
Market Cap:1.05B
PE:191.50
High:7.85
Open:7.72
Low:7.65
Close:7.75
Loading ...

High Growth Tech Stocks To Watch In The US Market

Simply Wall St.
·
08 Apr

Aurinia Pharmaceuticals Inc. (AUPH): Among Stocks Receiving the Most Insider Love in March

Insider Monkey
·
25 Mar

Strength Seen in Xeris Biopharma (XERS): Can Its 5.6% Jump Turn into More Strength?

Zacks
·
20 Mar

Aurinia Pharmaceuticals CMO Makes Significant Stock Sale

TIPRANKS
·
08 Mar

Signet Jewelers, Big Bear, and More Stocks See Action From Activist Investors -- Barrons.com

Dow Jones
·
08 Mar

Major Investment Alert: Kevin Tang Boosts Stake in Aurinia Pharmaceuticals

TIPRANKS
·
05 Mar

Are Options Traders Betting on a Big Move in Aurinia Pharmaceuticals (AUPH) Stock?

Zacks
·
05 Mar

Results: Aurinia Pharmaceuticals Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates

Simply Wall St.
·
02 Mar

Stock Track | Aurinia Pharmaceuticals Soars 5% as 2024 Earnings Beat Expectations

Stock Track
·
01 Mar

RBC Lowers Price Target on Aurinia Pharmaceuticals to $8 From $9, Keeps Outperform, Speculative Risk

MT Newswires Live
·
28 Feb

Aurinia Pharmaceuticals Full Year 2024 Earnings: EPS Beats Expectations

Simply Wall St.
·
28 Feb

Aurinia Pharmaceuticals Inc (AUPH) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

GuruFocus.com
·
28 Feb

Regulatory and Financial Challenges Loom for Aurinia Pharmaceuticals Despite FDA and EC Approvals

TIPRANKS
·
28 Feb

Aurinia Pharmaceuticals Reports Strong 2024 Financial Growth

TIPRANKS
·
28 Feb

Aurinia Pharmaceuticals Reports Balanced Earnings with Growth and Challenges

TIPRANKS
·
28 Feb

Autoimmune Disease-Focused Aurinia Pharmaceuticals Reports Quarterly Profit, Revenue Outlook Below Expectations

Benzinga
·
28 Feb

Stock Track | Aurinia Pharmaceuticals Plummets 13.46% as Q4 Earnings and Guidance Disappoint Investors

Stock Track
·
27 Feb

Aurinia Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
27 Feb

Aurinia Pharmaceuticals Swings to Q4 Earnings, Revenue Rises

MT Newswires Live
·
27 Feb

Aurinia Pharmaceuticals (AUPH) Beats Q4 Earnings and Revenue Estimates

Zacks
·
27 Feb